AnatomyOrganismsDiseasesChemicals and DrugsAnalytical, Diagnostic and Therapeutic Techniques and EquipmentPsychiatry and PsychologyPhenomena and ProcessesDisciplines and OccupationsAnthropology, Education, Sociology and Social PhenomenaTechnology, Industry, AgricultureInformation ScienceNamed GroupsHealth CareGeographicals
Esophageal NeoplasmsAntineoplastic AgentsNeoplasmsCell Line, TumorEsophagectomyDrug Screening Assays, AntitumorCarcinoma, Squamous CellRadiation DosageRadiation, IonizingRadiation InjuriesDrug Resistance, NeoplasmApoptosisCisplatinDoxorubicinRadiation ToleranceAntineoplastic Agents, PhytogenicAdenocarcinomaMice, NudeBreast NeoplasmsCell SurvivalDose-Response Relationship, RadiationXenograft Model Antitumor AssaysDrug Delivery SystemsTumor Cells, CulturedCombined Modality TherapyGene Expression Regulation, NeoplasticAntibiotics, AntineoplasticFluorouracilCell ProliferationPaclitaxelRadiationEsophagusAntineoplastic Combined Chemotherapy ProtocolsLung NeoplasmsDrug CarriersColonic NeoplasmsRadiotherapyRadiation ProtectionCamptothecinDose-Response Relationship, DrugRadiation MonitoringNeoplasm StagingNeoplasm ProteinsPrognosisProstatic NeoplasmsStomach NeoplasmsTreatment OutcomeDNA DamageCell CycleTumor Suppressor Protein p53Radiotherapy DosageInhibitory Concentration 50EllipticinesSurvival RateDrug SynergismDrug Resistance, MultipleOvarian NeoplasmsEtoposideMolecular Targeted TherapySurvival AnalysisChinaChemoradiotherapyEarly Detection of CancerRadiation-Sensitizing AgentsDrug DesignP-GlycoproteinNeoplasm TransplantationNeoplasm MetastasisTime FactorsEsophagoscopyRetrospective StudiesBlotting, WesternEnzyme InhibitorsCarcinomaTumor BurdenClinical Trials as TopicNeoplasm InvasivenessRadiation OncologyProdrugsTumor Markers, BiologicalSignal TransductionOrganoplatinum CompoundsReverse Transcriptase Polymerase Chain ReactionMolecular StructureMedical OncologyRNA, MessengerAntimetabolites, AntineoplasticRNA, Small InterferingCell DivisionRadiotherapy, AdjuvantNational Cancer Institute (U.S.)Transplantation, HeterologousNanomedicineNanoparticlesRisk FactorsPancreatic NeoplasmsAnticarcinogenic AgentsDNA, NeoplasmDown-RegulationFollow-Up Studies